| 2815 |
1686: Energy Deposition |
2083: Cataracts |
Dec 18, 2022 |
Mar 11, 2024 |
1 AOP
|
| 2832 |
1686: Energy Deposition |
1492: Tissue resident cell activation |
Jan 25, 2023 |
Mar 21, 2023 |
1 AOP
|
| 2837 |
1686: Energy Deposition |
2098: Abnormal Neural Remodeling |
Jan 25, 2023 |
Feb 14, 2024 |
1 AOP
|
| 2838 |
1686: Energy Deposition |
341: Impairment, Learning and memory |
Jan 25, 2023 |
Mar 21, 2023 |
1 AOP
|
| 2847 |
1686: Energy Deposition |
2089: Altered Bone Cell Homeostasis |
Jan 25, 2023 |
Mar 22, 2023 |
1 AOP
|
| 2848 |
1686: Energy Deposition |
2090: Bone Remodeling |
Jan 25, 2023 |
Mar 22, 2023 |
1 AOP
|
| 2849 |
1686: Energy Deposition |
2091: Bone Loss |
Jan 25, 2023 |
Mar 22, 2023 |
1 AOP
|
| 1798 |
1550: Ionizing Energy |
1553: Increase mutations |
Dec 19, 2018 |
Dec 19, 2018 |
None
|
| 1799 |
1550: Ionizing Energy |
1554: Increase chromosomal aberrations |
Dec 19, 2018 |
Dec 19, 2018 |
None
|
| 2379 |
1550: Ionizing Energy |
1115: Increased, Reactive oxygen species |
May 12, 2021 |
May 12, 2021 |
1 AOP
|
| 2380 |
1550: Ionizing Energy |
1194: Increase, DNA Damage |
May 12, 2021 |
May 12, 2021 |
1 AOP
|
| 2390 |
1550: Ionizing Energy |
1088: Increased, Oxidative Stress |
May 12, 2021 |
May 12, 2021 |
1 AOP
|
| 2392 |
1550: Ionizing Energy |
752: Altered, Meiotic chromosome dynamics |
May 14, 2021 |
May 14, 2021 |
1 AOP
|
| 2393 |
1550: Ionizing Energy |
1798: Decreased spermatogenesis |
May 14, 2021 |
May 14, 2021 |
1 AOP
|
| 2394 |
1550: Ionizing Energy |
406: impaired, Fertility |
May 14, 2021 |
May 14, 2021 |
1 AOP
|
| 2395 |
1550: Ionizing Energy |
1696: Decrease of egg production and cummulative fecundity |
May 14, 2021 |
May 14, 2021 |
1 AOP
|
| 2396 |
1550: Ionizing Energy |
997: Decreased, Population size |
May 14, 2021 |
May 14, 2021 |
1 AOP
|
| 2397 |
1550: Ionizing Energy |
1775: Increase, Oocyte apoptosis |
May 14, 2021 |
May 14, 2021 |
1 AOP
|
| 2921 |
2138: Derease, testosterone levels |
219: Reduction, Plasma 17beta-estradiol concentrations |
May 22, 2023 |
May 22, 2023 |
None
|
| 2925 |
2138: Derease, testosterone levels |
2139: Reduction, the ratio of E2/11-KT in plasma |
May 22, 2023 |
May 22, 2023 |
None
|
| 659 |
663: Desensitization, Nicotinic acetylcholine receptor |
386: Neuronal network function, Decreased |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1309 |
663: Desensitization, Nicotinic acetylcholine receptor |
1243: Altered, Ca2+-calmodulin activated signal transduction |
Nov 29, 2016 |
Dec 3, 2016 |
2 AOPs
|
| 1356 |
1272: Differentiation of Myofibroblast |
1274: Production of α-smooth muscle actin |
Feb 15, 2017 |
Feb 15, 2017 |
None
|
| 973 |
944: dimerization, AHR/ARNT |
945: reduced dimerization, ARNT/HIF1-alpha |
Nov 29, 2016 |
Mar 23, 2018 |
2 AOPs
|
| 1350 |
944: dimerization, AHR/ARNT |
1269: Increase, COX-2 expression |
Feb 9, 2017 |
May 9, 2017 |
1 AOP
|